Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$933B
| $313M | 0.37% |
6,143,852
+1,156,591
| +23% | +$62M |
|
|
VXX
27
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $304M | 0.36% |
339,332
+102,551
| +43% | +$103M |
|
28
CALL
Qualcomm
QCOM
$160B
| $300M | 0.36% |
4,481,500
+3,407,000
| +317% | +$223M |
|
|
29
Pfizer
PFE
$142B
| $298M | 0.36% |
11,200,672
-17,234,180
| -61% | -$469M |
|
30
Procter & Gamble
PG
$335B
| $288M | 0.34% |
3,841,872
+739,491
| +24% | +$58.8M |
|
|
VXX
31
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $280M | 0.33% |
312,366
+14,275
| +5% | +$14.3M |
|
32
CALL
Walt Disney
DIS
$167B
| $274M | 0.33% |
4,283,100
+726,800
| +20% | +$46.6M |
|
33
PUT
Tesla
TSLA
$1.22T
| $257M | 0.31% |
19,953,000
+10,443,000
| +110% | +$103M |
|
34
IBM
IBM
$209B
| $249M | 0.3% |
1,407,625
+203,283
| +17% | +$36.9M |
|
35
CALL
Johnson & Johnson
JNJ
$617B
| $246M | 0.29% |
2,864,700
-333,200
| -10% | -$29.9M |
|
36
Merck
MRK
$321B
| $243M | 0.29% |
5,424,969
+97,375
| +2% | +$4.45M |
|
37
PUT
iShares MSCI Brazil ETF
EWZ
$9.25B
| $242M | 0.29% |
5,139,900
+2,218,500
| +76% | +$98.6M |
|
|
VXX
38
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $241M | 0.29% |
269,215
-40,635
| -13% | -$40.7M |
|
39
Wells Fargo
WFC
$258B
| $232M | 0.28% |
5,658,786
+541,645
| +11% | +$23.1M |
|
|
40
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
| $232M | 0.28% |
2,184,100
+632,800
| +41% | +$67M |
|
41
Bank of America
BAC
$433B
| $229M | 0.27% |
17,602,643
-4,957,286
| -22% | -$70.8M |
|
42
PUT
Meta Platforms (Facebook)
META
$1.37T
| $218M | 0.26% |
4,351,000
+2,512,400
| +137% | +$93.5M |
|
43
Intel
INTC
$460B
| $213M | 0.25% |
9,700,084
+2,449,861
| +34% | +$56.4M |
|
|
44
Southern Company
SO
$106B
| $211M | 0.25% |
5,149,652
+4,214,038
| +450% | +$182M |
|
45
Berkshire Hathaway Class B
BRK.B
$1.1T
| $210M | 0.25% |
1,857,191
+598,409
| +48% | +$69M |
|
46
PUT
VanEck Gold Miners ETF
GDX
$23.5B
| $209M | 0.25% |
8,359,100
+2,387,200
| +40% | +$63.5M |
|
47
PUT
iShares MSCI EAFE ETF
EFA
$78.5B
| $205M | 0.25% |
3,257,200
-6,114,100
| -65% | -$375M |
|
48
Cisco
CSCO
$448B
| $205M | 0.24% |
8,892,241
+2,688,804
| +43% | +$66.8M |
|
|
ONXX
49
CALL
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $204M | 0.24% |
1,643,800
+1,474,900
| +873% | +$187M |
|
|
ONXX
50
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $193M | 0.23% |
1,553,089
+1,353,524
| +678% | +$171M |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.